来历不明的肿瘤患者的近似

J. Molinos, Antonio Cobo Molinos
{"title":"来历不明的肿瘤患者的近似","authors":"J. Molinos, Antonio Cobo Molinos","doi":"10.4172/2329-6771.1000190","DOIUrl":null,"url":null,"abstract":"The tumor of unknown origin constitutes 3-7% of the cancers studied and is one of the 10 most frequent cancer diagnoses. It is a malignant tumor whose first origin or identification is not done in the clinical history, in the clinical exploration or in the complementary studies. At present, the effort in the primary search for the origin of the cancer that will be directed at specifying these entities and recognizing them as soon as possible is arduous. Today we have several techniques among which we highlight immunohistochemistry, molecular biology and radiodiagnosis that greatly facilitate the work of the clinician in detecting the origin of tumors, although none of them is conclusive.","PeriodicalId":16252,"journal":{"name":"Journal of Integrative Oncology","volume":"75 1","pages":"1-3"},"PeriodicalIF":0.0000,"publicationDate":"2017-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Approximation to the Patient with Tumor of Unknown Origin\",\"authors\":\"J. Molinos, Antonio Cobo Molinos\",\"doi\":\"10.4172/2329-6771.1000190\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The tumor of unknown origin constitutes 3-7% of the cancers studied and is one of the 10 most frequent cancer diagnoses. It is a malignant tumor whose first origin or identification is not done in the clinical history, in the clinical exploration or in the complementary studies. At present, the effort in the primary search for the origin of the cancer that will be directed at specifying these entities and recognizing them as soon as possible is arduous. Today we have several techniques among which we highlight immunohistochemistry, molecular biology and radiodiagnosis that greatly facilitate the work of the clinician in detecting the origin of tumors, although none of them is conclusive.\",\"PeriodicalId\":16252,\"journal\":{\"name\":\"Journal of Integrative Oncology\",\"volume\":\"75 1\",\"pages\":\"1-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-03-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Integrative Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2329-6771.1000190\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Integrative Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2329-6771.1000190","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

来源不明的肿瘤占所研究癌症的3-7%,是10种最常见的癌症诊断之一。它是一种在临床病史、临床探索或补充研究中未进行首次起源或鉴定的恶性肿瘤。目前,对癌症起源的初步研究旨在确定这些实体并尽快识别它们,这是一项艰巨的工作。今天,我们有几种技术,其中我们强调免疫组织化学,分子生物学和放射诊断,极大地促进了临床医生在检测肿瘤起源的工作,尽管它们都不是结论性的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Approximation to the Patient with Tumor of Unknown Origin
The tumor of unknown origin constitutes 3-7% of the cancers studied and is one of the 10 most frequent cancer diagnoses. It is a malignant tumor whose first origin or identification is not done in the clinical history, in the clinical exploration or in the complementary studies. At present, the effort in the primary search for the origin of the cancer that will be directed at specifying these entities and recognizing them as soon as possible is arduous. Today we have several techniques among which we highlight immunohistochemistry, molecular biology and radiodiagnosis that greatly facilitate the work of the clinician in detecting the origin of tumors, although none of them is conclusive.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Time-restricted Eating to Address Cancer-related Fatigue among Cancer Survivors: A Single-arm Pilot Study. PROGNOSTIC IMPORTANCE OF MOLECULAR GENETIC MARKERS: Ki67, Bcl2, and p53 IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER Role of Vitronectin as a potential Serum Biomarker for Breast Cancer Prognosis Botulinum Toxin Usefulness in the Treatment of Drooling in Childhood Breast cancer risk factors, prevention and patients empowerment
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1